
ISPOR's Value Assessment Stakeholder Conference showed its Special Task Force still reaching for clarification around the subject, writes Ansis Helmanis.
Ansis Helmanis is a former FDA official and founder of RegLink Associates.
Published: October 1st 2011 | Updated:
Published: October 1st 2011 | Updated:
Published: September 28th 2016 | Updated: